Diagnosis and treatment of severe pediatric pulmonary hypertension

Area of Science:

• Cardiovascular Medicine
• Pediatric Pulmonology
• Vascular Biology

Background:

• Pulmonary hypertension (PH) significantly impacts morbidity and mortality in pediatric patients, particularly those with congenital heart disease.
• Recent decades have seen major improvements in patient survival due to therapeutic advancements.
• A deeper understanding of pulmonary vascular biology underpins these treatment breakthroughs.

Purpose of the Study:

• To review current diagnostic approaches for primary and secondary pulmonary hypertension.
• To outline contemporary treatment strategies for pulmonary hypertension in pediatric populations.
• To provide an overview of the vascular biology relevant to pulmonary hypertension.

Main Methods:

• Literature review of recent advancements in pulmonary hypertension diagnosis and treatment.
• Synthesis of current understanding of pulmonary vascular biology.
• Focus on primary and secondary forms of pulmonary hypertension, with emphasis on pediatric cases.

Main Results:

• Improved understanding of vascular biology has driven therapeutic progress.
• Current diagnostic tools allow for earlier and more accurate identification of PH.
• A range of treatments are available, targeting different aspects of the disease.

Conclusions:

• Therapeutic progress in pulmonary hypertension is closely linked to advances in vascular biology.
• Comprehensive diagnostic strategies are crucial for effective management.
• Effective treatment of pulmonary hypertension, especially in pediatric patients, remains a critical area of clinical focus.